Administration of primaquine has significant limitations, including serious haemolysis risks in individuals with glucose‐6‐phosphate‐dehydrogenase enzyme (G6PD) deficiency [34]. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.